| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 02/07/2002 | US20020015701 Inhibiting properdin-induced stabilization of C3 convertase by exposure to an anti-properdin antibody |
| 02/07/2002 | US20020015700 Inhibiting the interaction of a cell bearing mammalian chemokine receptor 2 (CCR2) with a ligand by binding with antibodies or functional fragments |
| 02/07/2002 | US20020015693 Inducing an immune response to a T-cell independent antigen in a host, comprises administering to the host cell an interleukin-12 and T-cell independent antigen such as a carbohydrate, a lipid, a glycolipid and a carrier conjugate |
| 02/07/2002 | DE10035156A1 New protein complex containing complex protein from botulinum toxin, useful for oral delivery of therapeutic polypeptide or low molecular weight pharmaceutical |
| 02/07/2002 | DE10034607A1 Multispezifisches Reagenz zur selektiven Stimulierung von Zelloberflächenrezeptoren Multi-specific reagent for the selective stimulation of cell surface receptors |
| 02/07/2002 | CA2771263A1 Therapeutic polyesters and polyamides |
| 02/07/2002 | CA2425037A1 Vaccines comprising outer membrane vesciles from gram negative bacteria |
| 02/07/2002 | CA2418115A1 Imidazole derivatives |
| 02/07/2002 | CA2418036A1 Innate immune system-directed vaccines |
| 02/07/2002 | CA2417900A1 C3b/c4b complement receptor-like molecules and uses thereof |
| 02/07/2002 | CA2417788A1 Novel coumarin derivatives and the salts thereof, a process for the preparation thereof and their use in the pharmaceutical field |
| 02/07/2002 | CA2417719A1 Improved virus like particles based on small envelope protein from hepatitis b (hbsag-s) |
| 02/07/2002 | CA2417650A1 Indazole derivatives as jnk inhibitors and compositions and methods related thereto |
| 02/07/2002 | CA2417638A1 Carboxamide compounds and their use as antagonists of a human 11cby receptor |
| 02/07/2002 | CA2417636A1 Non-peptide ccr1 receptor antagonists in combination with cyclosporin a for the treatment of heart transplant rejection |
| 02/07/2002 | CA2417612A1 C3b/c4b complement receptor-like molecules and uses thereof |
| 02/07/2002 | CA2417574A1 Modified sialic acid vaccines |
| 02/07/2002 | CA2417444A1 Nonsteroidal inflammation inhibitors |
| 02/07/2002 | CA2417364A1 Compositions for and methods of using herpes simplex virus glycoprotein d to suppress immune responses |
| 02/07/2002 | CA2417359A1 Protein phosphatases |
| 02/07/2002 | CA2417356A1 Directed differentiation of embryonic cells |
| 02/07/2002 | CA2417349A1 Novel proteins and nucleic acids encoding same |
| 02/07/2002 | CA2417277A1 3-indolyl-4-phenyl-1h-pyrrole-2,5-dione derivatives as inhibitors of glycogen synthase kinase-3.beta. |
| 02/07/2002 | CA2417259A1 Process for preparing arylacetylaminothiazoles |
| 02/07/2002 | CA2417254A1 N-¢5-¢¢¢5-alkyl-2-oxazolyl!methyl!thio!-2-thiazolyl! carboxamide inhibitors of cyclin dependent kinases |
| 02/07/2002 | CA2417204A1 Imidazolyl derivatives |
| 02/07/2002 | CA2417195A1 G-protein coupled receptors |
| 02/07/2002 | CA2417059A1 3-substituted isoquinolin-1-yl derivatives |
| 02/07/2002 | CA2416820A1 Isolated nucleic acid molecules which encode t cell inducible factors, or interleukin-21, the proteins encoded, and uses thereof |
| 02/07/2002 | CA2415851A1 Hexahydro-7-1h-azepin-2-yl-haxanoic acid derivatives as inhibitors of inducible nitric oxide synthase |
| 02/07/2002 | CA2415473A1 Apo-2l receptor agonist and cpt-11 synergism |
| 02/07/2002 | CA2415189A1 Immunomodulatory compounds |
| 02/07/2002 | CA2406311A1 Method for preventing and curing diseases of an immune system and a remedy for carrying out said method |
| 02/07/2002 | CA2388550A1 Dispersions for formulating slightly or poorly soluble active ingredients |
| 02/06/2002 | EP1178041A1 Process for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives |
| 02/06/2002 | EP1177795A2 Use of ethylene glycol esters of monohydrobenzoporphyrin derivatives as photoactive agents |
| 02/06/2002 | EP1177794A2 Composition, containing lactobacillus bulgaricus and streptococcus thermophilus, for the treatment of gastrointestinal disorders, hyperlipidemia, autoimmune diseases, and obesity |
| 02/06/2002 | EP1177312A2 Human gil-19/ae289 proteins and polynucleotides encoding same |
| 02/06/2002 | EP1177296A2 Extracellular matrix and adhesion-associated proteins |
| 02/06/2002 | EP1177295A1 Ox2 receptor homologs |
| 02/06/2002 | EP1177292A2 Family of immunoregulators designated leukocyte immunoglobulin-like receptors (lir) |
| 02/06/2002 | EP1177186A1 Ureas and their use as cell adhesion modulators |
| 02/06/2002 | EP1177175A2 Heterosubstituted pyridine derivatives as pde 4 inhibitors |
| 02/06/2002 | EP1177173A1 Hydroxamic acid derivatives as matrix metalloprotease inhibitors |
| 02/06/2002 | EP1177168A1 Caspase inhibitors and the use thereof |
| 02/06/2002 | EP1176986A1 Differentiation of monocytes into functional dendritic cells |
| 02/06/2002 | EP1176985A2 Enzymatically activated polymeric drug conjugates |
| 02/06/2002 | EP1176981A1 Treatment of autoimmune diseases with antagonists which bind to b cell surface markers |
| 02/06/2002 | EP1176980A1 Ccr4 antagonists in sepsis |
| 02/06/2002 | EP1176972A1 Use of phyllanthus for targeted stimulation of the immune system |
| 02/06/2002 | EP1176971A1 Use of phyllanthus for treating chronically inflammatory and fibrotic processes |
| 02/06/2002 | EP1176965A1 Antisense modulation of fas mediated signaling |
| 02/06/2002 | EP1176956A1 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors |
| 02/06/2002 | EP1176948A1 Anti-nausea compositions and methods |
| 02/06/2002 | EP1176870A2 Tgf-alpha polypeptides, functional fragments and methods of use therefor |
| 02/06/2002 | EP0931084B1 1,3-dicarboxylic germanium complex and its therapeutic use |
| 02/06/2002 | EP0892794B1 Acylated n-hydroxy methyl thalidomide prodrugs with immunomodulator action |
| 02/06/2002 | EP0866865B1 Chimeric oligomers having an rna-cleavage activity |
| 02/06/2002 | EP0762888B1 Copolymer-1 improvements in compositions of copolymers |
| 02/06/2002 | EP0734386B1 Platelet activating factor antagonists: imidazopyridine indoles |
| 02/06/2002 | EP0712936B1 Low-molecular dna from sturgeon milt, a method of obtaining the dna and a pharmaceutical preparation based on it |
| 02/06/2002 | EP0547163B1 Protein polyligands joined to a stable protein core |
| 02/06/2002 | CN1334875A Cell signalling polypeptides and nucleic acids |
| 02/06/2002 | CN1334821A Humanized antibodies to gamma-interferon |
| 02/06/2002 | CN1334820A Connective tissue growth factor fragments and methods and uses thereof |
| 02/06/2002 | CN1334819A Connective tissue growth factor fragments and methods and uses thereof |
| 02/06/2002 | CN1334815A Methotrexate derivatives |
| 02/06/2002 | CN1334813A Method for preparing (R)-(+)-3-{1-[2-(4-benzoyl-2-(3,4-difluorophenyl) morpholin-2-yl)ethyl]-4-phenylpiperdin-4-yl}-1,1-dimethylurea, its salts solvates and/or hydrates |
| 02/06/2002 | CN1334812A Piperazine derivatives |
| 02/06/2002 | CN1334809A Nonsteroidal antiinflammatories |
| 02/06/2002 | CN1334807A 1-heterocycle substd. diarylamines |
| 02/06/2002 | CN1334802A Ligands of nuclear receptor |
| 02/06/2002 | CN1334800A 3,4,5-trisubstd. aryl nitrone compounds and pharmaceutical compositions contg. same |
| 02/06/2002 | CN1334736A Modulation of immune response by ribavirin |
| 02/06/2002 | CN1334730A Vitronectin receptor antagonist |
| 02/06/2002 | CN1334726A Hydroxy diphenyl urea sulfonamides as IL-8 receptor antagonists |
| 02/06/2002 | CN1078887C Sulfur-contg. di-tert-bytylphenol compounds useful as anti-inflammatory agents |
| 02/05/2002 | US6344563 Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systems |
| 02/05/2002 | US6344544 Semaphorin-specific antibodies |
| 02/05/2002 | US6344470 Aminothiazole derivatives, method of preparation and pharmaceutical compositions containing same |
| 02/05/2002 | US6344467 Antiasthmatic, antiallergic and immunosuppressant/immunomodulating properties |
| 02/05/2002 | US6344465 Inhibitors of IMPDH enzyme |
| 02/05/2002 | US6344464 Use of tetrahydropyridine derivatives to prepare medicines for treating diseases causing demyelination |
| 02/05/2002 | US6344463 Skin disorders, acne |
| 02/05/2002 | US6344462 Heterocyclic compounds as bradykinin antagonists |
| 02/05/2002 | US6344450 Lactam compounds and their use as inhibitors of serine proteases and method |
| 02/05/2002 | US6344449 Headache and morphine dependence |
| 02/05/2002 | US6344314 Determined DNA sequenced derived from a papillomavirus genome, their uses for in vitro diagnostic purposes and the production of antigenic compositions |
| 02/05/2002 | US6344194 Dissolving a virus in an aqueous solution containing 6-12 g/l of a monovalent cation salt (such as nacl or kcl), or 50-100 g/l of a hexose and atomizing |
| 02/05/2002 | CA2218289C Cd45rb binding compounds for the prevention of transplant rejection |
| 02/05/2002 | CA2123403C Acyclic ethylenediamine derivatives as substance p receptor antagonists |
| 02/05/2002 | CA2051418C Novel vitamin d analogues |
| 02/05/2002 | CA2050623C Ointments containing tricyclic compound |
| 01/31/2002 | WO2002008434A2 Bicistronic influenza comprising two genes in tandem |
| 01/31/2002 | WO2002008399A2 Human kinases |
| 01/31/2002 | WO2002008396A2 Human proteases |
| 01/31/2002 | WO2002008291A2 Multi-specific reagent for selective stimulation of cell surface receptors |
| 01/31/2002 | WO2002008285A2 Il-17 molecules and uses thereof |
| 01/31/2002 | WO2002008272A2 High affinity soluble interleukin-18 receptor |
| 01/31/2002 | WO2002008268A2 Leucine-based motif and clostridial neurotoxins |